News and Press Releases
Press releases
Theralase to Present at Global Investment Conference
Toronto, Ontario – September 12, 2016, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading bio...
0Theralase Increases Revenue 32% in 2H2016 Financials
Toronto, Ontario – Aug 29, 2016, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotech c...
0Theralase Extends Research Agreement with University Health Network
Toronto, Ontario – April 28, 2016, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotech c...
0Theralase Files ITA Application to Health Canada
Toronto, Ontario – July 29, 2016, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotech ...
0Theralase Files Dosimetry Fibre Optic Cage Patent Application
Toronto, Ontario – June 22, 2016, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotech ...
0Theralase Granted US Patent for Lead Anti-Cancer Drug
Toronto, Ontario – June 20, 2016, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotech ...
0Theralase Granted US Patent for Lead Anti-Cancer Drug
Toronto, Ontario – June 20, 2016, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotech ...
0Theralase Signs Clinical Research Agreement with University Health Network
Toronto, Ontario – May 12, 2016, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotech c...
0Theralase Presents Anti-Cancer Technology at 111th Annual American Urological Association Meeting
Toronto, Ontario – May 11, 2016, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotech c...
0Theralase Increases Revenue 40% in 2015 Financials
Toronto, Ontario – April 29, 2016, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotech c...
0in the news
July 6, 2023
Vrian Crombie Radio Interview with Roger DuMoulin-White - President and Chief Executive Officer
may 18, 2023
Promising Developments in the Theralase® Project of Intravesical Photodynamic Therapy for BCG Unresponsive Bladder Cancer - Girish Kulkarni
Let's Stay in Touch
Sign up to our newsletter to stay informed on news and updates from Theralase Technologies Inc.